Compile Data Set for Download or QSAR
Report error Found 17 Enz. Inhib. hit(s) with all data for entry = 12135
TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM50541002(CHEMBL4642420 | US12017994, Ref #20')
Affinity DataIC50: 118nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM50541003(CHEMBL4641808 | US12017994, Ref #23')
Affinity DataIC50: 142nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM50541004(CHEMBL4640688 | US12017994, Ref #10')
Affinity DataIC50: 347nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM50541005(CHEMBL4642057 | US12017994, Ref #12')
Affinity DataIC50: 468nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM50541006(CHEMBL4632679 | US12017994, Ref #6')
Affinity DataIC50: 759nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM682016(US12017994, Ref #45')
Affinity DataIC50: 1.11E+3nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM682013(US12017994, Ref #38')
Affinity DataIC50: 1.66E+3nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM682012(US12017994, Ref #36')
Affinity DataIC50: 3.71E+3nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM682004(US12017994, Ref #14')
Affinity DataIC50: 6.16E+3nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM682008(US12017994, Ref #29')
Affinity DataIC50: 6.44E+3nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM682004(US12017994, Ref #14')
Affinity DataIC50: 6.44E+3nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM682014(US12017994, Ref #41')
Affinity DataIC50: 6.73E+3nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM682009(US12017994, Ref #30')
Affinity DataIC50: 1.30E+4nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM682015(US12017994, Ref #44')
Affinity DataIC50: 1.91E+4nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM682005(US12017994, Ref #18')
Affinity DataIC50: 5.00E+4nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM682011(US12017994, Ref #34')
Affinity DataIC50: 5.00E+4nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent

TargetBeta-glucuronidase(Escherichia coli (strain K12))
Symberix

US Patent
LigandPNGBDBM682010(US12017994, Ref #31')
Affinity DataIC50: 5.00E+4nMAssay Description:Successful drug candidate compounds were subjected to numerous biochemical and cellular assays. Purified bacterial β-glucuronidases were challen...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/1/2024
Entry Details
US Patent